- Tytuł:
- Pharmacodynamic analysis of hypertension caused by lenvatinib using real-world postmarketing surveillance data.
- Autorzy:
- Źródło:
- CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2021 Mar; Vol. 10 (3), pp. 188-198. Date of Electronic Publication: 2021 Feb 14.
- Typ publikacji:
- Journal Article
- MeSH Terms:
-
Hypertension/*chemically induced
Phenylurea Compounds/*pharmacokinetics
Product Surveillance, Postmarketing/*methods
Protein Kinase Inhibitors/*pharmacokineticsQuinolines /*pharmacokinetics
Thyroid Neoplasms/*drug therapy
Aged ; Angiotensin Receptor Antagonists/pharmacology ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Antihypertensive Agents/pharmacology ; Area Under Curve ; Blood Pressure/drug effects ; Calcium Channel Blockers/pharmacology ; Dose-Response Relationship, Drug ; Drug-Related Side Effects and Adverse Reactions ; Female ; Humans ; Hypertension/drug therapy ; Japan/epidemiology ; Male ; Middle Aged ; Phenylurea Compounds/administration & dosage ; Phenylurea Compounds/adverse effects ; Phenylurea Compounds/pharmacology ; Product Surveillance, Postmarketing/statistics & numerical data ; Protein Kinase Inhibitors/administration & dosage ; Protein Kinase Inhibitors/adverse effects ; Protein Kinase Inhibitors/pharmacology ;Quinolines /administration & dosage ;Quinolines /adverse effects ;Quinolines /pharmacology ; Vascular Endothelial Growth Factor A
Czasopismo naukowe